Glow-in-the-Dark brain surgery: new hope for kids with tumors
NCT ID NCT06907485
First seen Jan 29, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tests a drug called Gleolan (5-ALA) in 20 children aged 2-18 with brain tumors. The drug makes tumor cells glow during surgery, helping surgeons remove more of the tumor. Children take the drug 6-12 hours before surgery and are monitored closely. A side effect is sensitivity to light, so they stay in dim light for 48 hours after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MidWest Children's Brain Tumor Center, Advocate Children's Hospital Park Ridge
Chicago, Illinois, 60068, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.